“
In general , if the lung was down , it would be up within a few hours and if not coming up within 48 hours , it was a referral to surgeons . Normally this would take five to seven days , but time to decision is now two days . Plus , we have reduced the number of interventions for the patient .”
We are supporting the Health Innovation Network as the lead organisation for the rollout of the MTFM product Spectra Optia across England . Through close collaboration with key stakeholders , including NHS England , the MTFM team , NHS England Specialised Commissioning , NHS Blood and Transplant , Terumo , and the Sickle Cell Society , we are seeing a huge expansion of automated red blood cell services for sickle cell patients where they are most needed and a significant reduction in health inequalities . You can read more about our progress to increase access to services and improve patient care outcomes for patients affected by sickle cell disease on page 22 .
Locally , we are working with our providers , NHS Blood and Transplant , and the North- East Yorkshire Haemoglobinopathy Coordinating Centre , to support increased use of automated red blood cell exchange for the sickle cell population in Yorkshire and the Humber . Our goal is to improve patient access by bringing this treatment closer to home . We are also working towards securing additional funding for emergency departments to provide automated red blood cell services and ensure availability outside of regular hours .
Dr Daniel Trushell- Pottinger , Consultant Respiratory Physician ,
Doncaster and Bassetlaw Teaching Hospitals NHS
Foundation Trust
16 Transforming Lives Through Innovation
© Babul Hosen / Shutterstock . com